Dyadic International (NASDAQ:DYAI) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Dyadic International (NASDAQ:DYAI) announced its earnings results on Wednesday. The biotechnology company reported ($0.05) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.01), Zacks reports. Dyadic International had a negative return on equity of 149.16% and a negative net margin of 188.09%.

Dyadic International Trading Down 3.6 %

Shares of NASDAQ:DYAI traded down $0.05 during midday trading on Wednesday, reaching $1.33. The company’s stock had a trading volume of 26,631 shares, compared to its average volume of 68,808. The firm has a market cap of $39.35 million, a price-to-earnings ratio of -5.78 and a beta of 0.95. The business has a 50 day moving average price of $1.48 and a 200 day moving average price of $1.42. Dyadic International has a 1 year low of $0.93 and a 1 year high of $2.67. The company has a quick ratio of 5.15, a current ratio of 5.15 and a debt-to-equity ratio of 1.54.

Institutional Trading of Dyadic International

An institutional investor recently raised its position in Dyadic International stock. Bank of America Corp DE lifted its stake in shares of Dyadic International, Inc. (NASDAQ:DYAI) by 16,146.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,132 shares of the biotechnology company’s stock after acquiring an additional 26,965 shares during the period. Bank of America Corp DE owned 0.09% of Dyadic International worth $47,000 as of its most recent SEC filing. 27.95% of the stock is owned by institutional investors.

About Dyadic International

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.